Want to see LMRI full AI Analyst Report?
Lumexa Imaging Holdings, Inc. (LMRI) Stock Price & Analysis
LMRI Stock Chart & Stats
- Day’s Range
- $11.26 - $11.88
- 52-Week Range
- $6.45 - $19.45
- Previous Close
- $11.73
- Volume
- 328.02K
- Average Volume (3M)
- 378.94K
- Market Cap
- $1.10B
- Enterprise Value
- $1.99B
- Total Cash (Recent Filing)
- $69.70M
- Total Debt (Recent Filing)
- $975.35M
- Price to Earnings (P/E)
- ―
- Beta
- 0.96
- Next Earnings
- Nov 10, 2026 (Est.)
- EPS Estimate
- 0.16
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Advanced Modality Mix
A rising advanced-modality mix supports Lumexa’s competitive positioning because these services generally receive higher reimbursement than routine scans. Continued PET and MRI growth can improve revenue quality, utilization, and future margin potential as the mix expands.
Improving Cash Generation
The sharp year-over-year improvement in operating and free cash flow demonstrates better earnings-to-cash conversion in the latest quarter. If sustained, stronger cash generation can support investment, debt reduction, and financial resilience while management targets 25%–30% annual conversion.
Deleveraging And Lower Interest Costs
Debt reduction and lower borrowing costs improve financial flexibility and should preserve more cash for operations and growth. The leverage improvement also reduces balance-sheet pressure, although the company remains meaningfully leveraged and must continue executing against its guidance.
Bears Say
Persistent Net Losses
Lumexa has not yet established durable bottom-line profitability despite sharply higher 2025 revenue. Persistent net losses and recent EBITDA margin compression limit internal funding capacity and leave results more sensitive to operating costs, financing expense, and execution risks.
Volatile Annual Cash Flow
The 2025 reversal in free cash flow indicates that revenue and reported operating performance have not consistently translated into cash. This volatility can constrain debt repayment and expansion funding, making sustained cash conversion an important requirement for the investment case.
Elevated Public-Company Costs
Higher public-company costs and stock-based compensation are weighing on reported profitability and contributed to year-over-year margin decline. Although some historic M&A-related expense should amortize, ongoing costs remain a structural drag until the business absorbs them through growth.
Lumexa Imaging Holdings, Inc. News
LMRI FAQ
What was Lumexa Imaging Holdings, Inc.’s price range in the past 12 months?
What is Lumexa Imaging Holdings, Inc.’s market cap?
When is Lumexa Imaging Holdings, Inc.’s upcoming earnings report date?
How were Lumexa Imaging Holdings, Inc.’s earnings last quarter?
Is Lumexa Imaging Holdings, Inc. overvalued?
Does Lumexa Imaging Holdings, Inc. pay dividends?
What is Lumexa Imaging Holdings, Inc.’s EPS estimate?
How many shares outstanding does Lumexa Imaging Holdings, Inc. have?
What happened to Lumexa Imaging Holdings, Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Lumexa Imaging Holdings, Inc.?
What is the TipRanks Smart Score and how is it calculated?
Lumexa Imaging Holdings, Inc. Stock Smart Score
Company Description
Lumexa Imaging Holdings, Inc.
Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.
- Sector
- General
- Industry
- Medical - Devices
- CEO
- Caitlin Zulla
- Employees
- 5,000
- Website
- www.lumexaimaging.com
- Address
- 4200 Six Forks Road, Raleigh, NC, 27609, US
Lumexa Imaging Holdings, Inc. (LMRI) Earnings & Revenues
LMRI Company Deck
LMRI Earnings Call
Earnings Call SentimentPositive
The call conveyed strong operational momentum and financial improvement: revenue and system-wide growth, record advanced modality mix, improved cash generation and deleveraging, PET and JV expansion, and platform/technology investment. Offsetting items include margin compression from public-company costs and elevated stock-based compensation, higher G&A, some routine-scan and payor-mix headwinds, and modeling complexity from JV pass-throughs. Management reiterated and narrowed guidance, signifying confidence in execution. Overall, positives around growth, cash flow, strategic partnerships and balance-sheet improvement materially outweigh the manageable cost and timing challenges discussed.
View all LMRI earnings summariesLMRI Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 6 | 4 |
| Technical Analysis | 3 | 6 | 1 |
| Moving Averages | 9 | 0 | 3 |







